These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis. Peres CM; de Paula L; Medeiros AI; Sorgi CA; Soares EG; Carlos D; Peters-Golden M; Silva CL; Faccioli LH Microbes Infect; 2007 Apr; 9(4):483-9. PubMed ID: 17347013 [TBL] [Abstract][Full Text] [Related]
4. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Yamashiro S; Kawakami K; Uezu K; Kinjo T; Miyagi K; Nakamura K; Saito A Clin Exp Immunol; 2005 Jan; 139(1):57-64. PubMed ID: 15606614 [TBL] [Abstract][Full Text] [Related]
5. CD27 contributes to the early systemic immune response to Mycobacterium tuberculosis infection but does not affect outcome. Wieland CW; Kerver ME; Florquin S; Nolte MA; Borst J; van Lier R; van Oers MH; van der Poll T Int Immunol; 2006 Nov; 18(11):1531-9. PubMed ID: 16966496 [TBL] [Abstract][Full Text] [Related]
6. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection. Bhatt K; Uzelac A; Mathur S; McBride A; Potian J; Salgame P J Immunol; 2009 Mar; 182(6):3793-800. PubMed ID: 19265158 [TBL] [Abstract][Full Text] [Related]
7. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice. Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352 [TBL] [Abstract][Full Text] [Related]
8. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150 [TBL] [Abstract][Full Text] [Related]
9. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice. Jung YJ; LaCourse R; Ryan L; North RJ J Exp Med; 2002 Oct; 196(7):991-8. PubMed ID: 12370260 [TBL] [Abstract][Full Text] [Related]
10. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. Wakeham J; Wang J; Magram J; Croitoru K; Harkness R; Dunn P; Zganiacz A; Xing Z J Immunol; 1998 Jun; 160(12):6101-11. PubMed ID: 9637527 [TBL] [Abstract][Full Text] [Related]
11. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. Kaneko H; Yamada H; Mizuno S; Udagawa T; Kazumi Y; Sekikawa K; Sugawara I Lab Invest; 1999 Apr; 79(4):379-86. PubMed ID: 10211990 [TBL] [Abstract][Full Text] [Related]
12. Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. Shryock N; McBerry C; Salazar Gonzalez RM; Janes S; Costa FT; Aliberti J PLoS One; 2013; 8(4):e61882. PubMed ID: 23613965 [TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end products is protective during murine tuberculosis. van Zoelen MA; Wieland CW; van der Windt GJ; Florquin S; Nawroth PP; Bierhaus A; van der Poll T Mol Immunol; 2012 Oct; 52(3-4):183-9. PubMed ID: 22698798 [TBL] [Abstract][Full Text] [Related]
15. Relative importance of NF-kappaB p50 in mycobacterial infection. Yamada H; Mizuno S; Reza-Gholizadeh M; Sugawara I Infect Immun; 2001 Nov; 69(11):7100-5. PubMed ID: 11598086 [TBL] [Abstract][Full Text] [Related]
16. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis. Tang K; Liu J; Yang Z; Zhang B; Zhang H; Huang C; Ma J; Shen GX; Ye D; Huang B Biochem Biophys Res Commun; 2010 Sep; 400(3):432-6. PubMed ID: 20801099 [TBL] [Abstract][Full Text] [Related]
17. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Olleros ML; Guler R; Vesin D; Parapanov R; Marchal G; Martinez-Soria E; Corazza N; Pache JC; Mueller C; Garcia I Am J Pathol; 2005 Apr; 166(4):1109-20. PubMed ID: 15793291 [TBL] [Abstract][Full Text] [Related]
18. Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma. Martins DR; Pelizon AC; Zorzella-Pezavento SF; Seger J; Santos Junior RR; Fonseca DM; Justulin LA; Silva CL; Sartori A Scand J Immunol; 2011 Apr; 73(4):293-300. PubMed ID: 21214611 [TBL] [Abstract][Full Text] [Related]
19. Restoration of innate immune activation accelerates Th1-cell priming and protection following pulmonary mycobacterial infection. Lai R; Jeyanathan M; Shaler CR; Damjanovic D; Khera A; Horvath C; Ashkar AA; Xing Z Eur J Immunol; 2014 May; 44(5):1375-86. PubMed ID: 24519467 [TBL] [Abstract][Full Text] [Related]
20. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Kahnert A; Seiler P; Stein M; Bandermann S; Hahnke K; Mollenkopf H; Kaufmann SH Eur J Immunol; 2006 Mar; 36(3):631-47. PubMed ID: 16479545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]